Cardiomyocyte Mineralocorticoid Receptors Are Essential for Deoxycorticosterone/Salt-Mediated Inflammation and Cardiac Fibrosis
- 1 December 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 60 (6), 1443-1450
- https://doi.org/10.1161/hypertensionaha.112.203158
Abstract
Because the role of mineralocorticoid receptors in specific cell types in cardiac remodeling remains unknown, we have compared cardiac responses with deoxycorticosterone/salt in cardiomyocyte mineralocorticoid receptor-null (MyoMRKO) and wild-type (WT) mice at 8 days and 8 weeks. No differences in cardiac function between untreated WT and MyoMRKO mice were found, whereas profibrotic markers were reduced in MyoMRKO hearts at baseline. At 8 days, MyoMRKO showed monocyte/macrophage recruitment equivalent to WT mice in response to deoxycorticosterone/salt but a suppression of markers of fibrosis compared with WT. At 8 weeks, MyoMRKO mice showed no deoxycorticosterone/salt-induced increase in inflammatory cell infiltration and collagen deposition or in proinflammatory gene expression. Although some profibrotic markers were equivalently increased in both genotypes, MyoMRKO mice also showed increased baseline levels of mRNA and protein for the transforming growth factor-β/connective tissue growth factor inhibitor decorin compared with WT that was accompanied by higher levels of matrix metalloproteinase 2/matrix metalloproteinase 9 activity. These data point to a direct role for cardiomyocyte mineralocorticoid receptor in both deoxycorticosterone/salt-induced tissue inflammation and remodeling and suggest potential mechanisms for the cardioprotective effects of selective mineralocorticoid receptor blockade in cardiomyocytes that may involve regulation of matrix metalloproteinase 2/matrix metalloproteinase 9 activity and the transforming growth factor-β-connective tissue growth factor profibrotic pathway.Keywords
This publication has 30 references indexed in Scilit:
- Ablation of Mineralocorticoid Receptors in Myocytes But Not in Fibroblasts Preserves Cardiac FunctionHypertension, 2011
- Cardiomyocyte Mineralocorticoid Receptor Function Post Myocardial InfarctionTrends in Cardiovascular Medicine, 2011
- Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood PressureHypertension, 2009
- Aldosterone and mineralocorticoid receptors: Clinical studies and basic biologyMolecular and Cellular Endocrinology, 2009
- Functional Mineralocorticoid Receptors in Human Vascular Endothelial Cells Regulate Intercellular Adhesion Molecule-1 Expression and Promote Leukocyte AdhesionCirculation Research, 2008
- Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammationCurrent Opinion in Nephrology and Hypertension, 2008
- Conditional Mineralocorticoid Receptor Expression in the Heart Leads to Life-Threatening ArrhythmiasCirculation, 2005
- 11β-Hydroxysteroid Dehydrogenase Type 2 in Mouse AortaHypertension, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureThe New England Journal of Medicine, 1999
- Mineralocorticoids, hypertension, and cardiac fibrosis.JCI Insight, 1994